The inauguration of the President on January 20, 2017 has been formally designated as a National Security Special Event (NSSE), the Congressional Research Service confirmed.
“NSSEs are high profile, and usually public, events that require significant security because of the attendance of U.S. and foreign dignitaries and the event’s public or official nature. The United States Secret Service (USSS) is designated as the primary federal entity responsible for NSSE security,” a newly updated CRS report explained.
See Inauguration Security: Operations, Appropriations, and Issues for Congress, January 11, 2017.
Other new and updated reports from the Congressional Research Service include the following.
Sanctuary Jurisdictions and Criminal Aliens: In Brief, updated January 10, 2017
U.S. Special Operations Forces (SOF): Background and Issues for Congress, updated January 6, 2017
Armed Conflict in Syria: Overview and U.S. Response, updated January 6, 2017
Israel: Background and U.S. Relations In Brief, updated January 6, 2017
Biennial Budgeting: Issues, Options, and Congressional Actions, January 10, 2017
Child Welfare: An Overview of Federal Programs and Their Current Funding, updated January 10, 2017
Constitutional Authority Statements and the Powers of Congress: An Overview, January 6, 2017
Military Retirement: Background and Recent Developments, updated January 6, 2017
Changes in the Arctic: Background and Issues for Congress, updated January 5, 2017
The transition to a clean energy future and diversified sources of energy requires a fundamental shift in how we produce and consume energy across all sectors of the U.S. economy.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.